Pharmacoidea Ltd.

PHARMACOIDEA Ltd. is an innovation-driven Hungarian biotech company specializing in drug discovery, pharma- and nutraceutical development, and advanced therapeutic solutions. Our research portfolio spans from next-generation nutraceuticals to molecularly-targeted drug delivery, biomarker discovery, and experimental therapeutics against SARS-CoV-2 infection. Our multidisciplinary team of scientists is dedicated to translating breakthrough research into real-world medical applications, addressing unmet medical needs with cutting-edge molecular pharmacology, and biotechnology tools. Pharmacoidea's proprietary brain delivery technology enables the transport of macromolecular agents across the blood-brain barrier, holding significant promise for Alzheimer’s disease therapy. With a robust bioinformatics-driven discovery platform, validated high-throughput bioassays, and transgenic animal models, Pharmacoidea accelerates the path from discovery to clinical translation. Our expertise extends to the compilation of drug discovery dossiers, integrating experimental data with regulatory-compliant evidence for therapeutic development. Pharmacoidea actively collaborates with leading international research initiatives, including the Innovative Health Initiative (IHI) and Innovative Medicines Initiative (IMI). The company remains committed to advancing personalized medicine and transforming healthcare through innovation.